EUVIMEDEUVIMED entdecken
Crossref

Palm-sized CRISPR sensing platform for on-site Mycoplasma pneumoniae detection

Jiajun Li, Haiqian Huang, Zerui Song, Shiying Chen, Jingsong Xu, Jun Yang, Chenyue Zheng, Yu Liu, Junheng Zhang, Li Cao, Qian Liu, Qiong Li und 3 weitere

Biosensors and Bioelectronics · 2025-08 · 281 · 117458

DOI: 10.1016/j.bios.2025.117458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-08. Verfasst von Jiajun Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Biosensing Techniques, Pneumonia, Mycoplasma, CRISPR-Cas Systems. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Institute of Molecular Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumonia remains a prevalent childhood illness and is the foremost cause of mortality due to infectious diseases among children under the age of five. Mycoplasma pneumoniae (M. pneumoniae) causes the most frequent type of atypical pneumonia in this age group, has raised global health concern. Therefore, there is a pressing need for a rapid, low cost, and user-friendly method for the early diagnosis of M. pneumoniae pneumonia. Herein, we develop a CRISPR sensing platform for on-site M. pneumoniae detection, termed CRAFT (Crispr-based rapid assay device for field testing). The CRAFT provides "sample in-result out" functionality. It completed sample processing and nucleic acid extraction within 5 min at room temperature, with efficiency comparable to commercial kits. RPA and CRISPR/Cas12a reagents were isolated in a closed tube using a movable magnetic bead valve, and the RPA product was then mixed with the CRISPR reagent. The limit of detection for M. pneumoniae using CRAFT was 100 copies/μL, and the method exhibited no cross-reactivity with other respiratory pathogens. CRAFT was utilized to validate 50 clinical samples, and the results demonstrated 100 % consistency with those obtained by qPCR. This versatile platform holds significant potential for point-of-care testing of M. pneumoniae, particularly in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma pneumoniaeBiosensing TechniquesPneumonia, MycoplasmaCRISPR-Cas SystemsHumansLimit of DetectionEquipment DesignNucleic Acid Amplification TechniquesDNA, Bacterial

Stichwörter der Autor:innen

CRISPR/Cas12aMagnetic bead valveMycoplasma pneumoniaePoint-of-care testing

Substanzen

DNA, Bacterial

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
  • Key Laboratory of Smart Manufacturing in Energy Chemical Process Ministry of Education, East China University of Science and Technology, Shanghai 200237, China.
  • Department of Pathology, The Fifth People's Hospital of Shanghai, 200240, Fudan University, China.
  • Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. Electronic address: qiongli@shsmu.edu.cn.
  • Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China; Shanghai Jiao Tong University School of Nursing. Shanghai Jiao Tong University, Shanghai, Chi…
  • Key Laboratory of Smart Manufacturing in Energy Chemical Process Ministry of Education, East China University of Science and Technology, Shanghai 200237, China. Electronic address: guzhen@ecust.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • Institute of Molecular Medicine, School of Medicine, Shanghai Jiao Tong University
  • Shanghai Jiao Tong University
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Huang, H., Song, Z., Chen, S., Xu, J., Yang, J., Zheng, C., Liu, Y., Zhang, J., Cao, L., Liu, Q., Li, Q., Li, M., Gu, Z., & Wang, H. (2025). Palm-sized CRISPR sensing platform for on-site Mycoplasma pneumoniae detection. Biosensors and Bioelectronics, 281, 117458. https://doi.org/10.1016/j.bios.2025.117458

Vancouver

Li J, Huang H, Song Z, Chen S, Xu J, Yang J, et al. Palm-sized CRISPR sensing platform for on-site Mycoplasma pneumoniae detection. Biosensors and Bioelectronics. 2025;281:117458. doi:10.1016/j.bios.2025.117458

BibTeX
@article{Li2025,
  author = {Li, Jiajun and Huang, Haiqian and Song, Zerui and Chen, Shiying and Xu, Jingsong and Yang, Jun and Zheng, Chenyue and Liu, Yu and Zhang, Junheng and Cao, Li and Liu, Qian and Li, Qiong and Li, Min and Gu, Zhen and Wang, Hua},
  title = {Palm-sized CRISPR sensing platform for on-site Mycoplasma pneumoniae detection},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  volume = {281},
  pages = {117458},
  doi = {10.1016/j.bios.2025.117458}
}
Kostenlos starten →